Abstract-Lipid-shelled microbubbles have been used in ultrasound-mediated drug delivery. The physicochemical properties of the microbubble shell could affect the delivery efficiency since they determine the microbubble mechanical properties, circulation persistence, and dissolution behavior during cavitation. Therefore, the aim of this study was to investigate the shell effects on drug delivery efficiency in the brain via blood-brain barrier (BBB) opening in vivo using monodisperse microbubbles with different phospholipid shell components. The physicochemical properties of the monolayer were varied by using phospholipids with different hydrophobic chain lengths (C16, C18, and C24). The dependence on the molecular size and acoustic energy (both pressure and pulse length) were investigated. Our results showed that a relatively small increase in the microbubble shell rigidity resulted in a significant increase in the delivery of 40-kDa dextran, especially at higher pressures. Smaller (3 kDa) dextran did not show significant difference in the delivery amount, suggesting the observed shell effect was molecular size-dependent. In studying the impact of acoustic energy on the shell effects, it was found that they occurred most significantly at pressures causing microbubble fragmentation (450 kPa and 600 kPa); by increasing the pulse length to deliver the 40-kDa dextran, the difference between C16 and C18 was eliminated while C24 achieved the highest delivery efficiency. These findings indicated that the acoustic parameters could be adjusted to modulate the shell effects. The acoustic cavitation emission revealed the physical mechanisms associated with different shells. Overall, lipid-shelled microbubbles with long hydrophobic chain length could achieve high delivery efficiency for larger molecules especially with high acoustic energy. Our study offered, for the first time, evidence directly linking the microbubble monolayer shell with their efficacy for drug delivery in vivo.
INTRODUCTION
Microbubbles have recently been shown critical in ultrasound-mediated drug delivery via sonoporation [1, 2] and via blood-brain barrier (BBB) opening [3, 4] . The microbubble properties play important roles in determining the delivery efficiency. For example, larger microbubbles (4-5 μm in diameter) induce larger BBB opening and delivery efficiency than smaller microbubbles (1-2 μm in diameter) [5, 6] ; soft-shelled (lipid or protein) microbubbles gave higher cell viability and transfection rate of gene delivery than hardshelled (polymer) microbubbles [7] . In order to maximize the efficacy without causing cell damage, high delivery efficiency was hypothesized to be achieved by changing the lipid hydrophobic chain length that modulates the overall physicochemical properties of the monolayer lipid-shelled microbubbles due to the varied the gas permeation resistance to the environment [8] , the acoustic dissolution rate, and the lipid-shedding phenomenon during insonification [9] .
This study aimed at investigating the shell effect of lipidcoated microbubbles on the drug delivery efficiency in vivo. We hypothesize that increasing the lipid hydrophobic chain length would enhance the drug delivery efficiency after focused ultrasound (FUS)-induced BBB opening. The microbubbles used were coated with phosphatidylcholine (PC) lipids of various acyl chains (C16, C18, C24), and the phospholipid:lipopolymer ratio was fixed in order to isolate the effect of the PC acyl chain length. In addition, the diameter of the microbubble samples was kept constant at 4-5 μm in all experiments in order to exclude the influence of the microbubble size. Both molecular size (3 kDa and 40 kDa dextran been delivered), acoustic pressure (225-600 kPa), and pulse length (100 cycles and 1000 cycles) dependences were investigated in order to fully assess the microbubble shell effects on the drug delivery efficiency.
The different shelled microbubble dynamics in vivo were also captured during insonification using passive acoustic cavitation detection (PCD) in order to potentially uncover the physical mechanisms affecting the delivery efficiency such as micro-streaming and micro-jetting. The signal recorded by PCD is the acoustic emission from the cavitating bubbles, which represents the cavitation intensity with the signature of stable and/or inertial cavitation.
II. METHODS

A. Microbubble Fabrication
All the lipids were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA), including 1,2-dipalmitoyl-snglycero-3-phosphocholine (DPPC or C16), 1,2-distearoyl-snglycero-3-phosphocholine (DSPC or C18), 1,2-978-1-4799-8182-3/15/$31.00 ©2015 IEEE 2015 IEEE International Ultrasonics Symposium Proceedings dilignoceroyl-sn-glycero-3-phosphocholine (DLiPC or C24) and 1,2-distearoyl-sn-glycero-3phosphoethanolamine-Nmethoxy (polyethylene glycol) 2000] (DSPE-PEG2000). The perfluorobutane gas (PFB, 99 wt% purity) used for microbubble generation was obtained from FluoroMed (Round Rock, TX, USA). The lipid-coated microbubbles were prepared at a 9:1 molar ratio of lipids and lipopolymers (DSPE-PEG2000), and size selected to 4-5 μm in diameter using differential centrifugation [10] .
B. In Vivo Experiment
All animal experiments (male C57BL/6 mice) were conducted in accordance with procedures approved by the Columbia University Institutional Animal Care and Use Committee. The model drugs, 3-kDa and 40-kDa Texas Redconjugated dextran with a Stoke-Einstein hydrodynamic diameter of 3 nm and 10 nm respectively (Life Technologies, Carlsbad, CA, USA), were dissolved to the same mass concentration (40 mg/mL) using sterile saline (Fisher Scientific, Pittsburgh, PA, USA) in separate experiments.
The experimental setup and procedure were described in the previous study [11] . A single-element, ring-shaped focused ultrasound (FUS) transducer was used with a confocally and coaxially aligned pulse-echo transducer for both targeting and passive cavitation detection (PCD) purposes. Pulsed FUS (excitation frequency: 1.5 MHz, pulsed length: 100 cycles (67 μs) or 1000 cycles (670 μs), pulse repetition frequency: 5 Hz, duration: 1 min) at acoustic pressures ranging between 225 and 600 kPa was applied transcranially to the targeted left hippocampus while the right hippocampus served as the control without FUS. A 30 s of sonication was performed before microbubble injection as a baseline control for PCD. Then, the microbubble samples were freshly diluted to a final concentration of 8×10 8 bubbles/mL using sterile saline, and a 30 μL of the diluted microbubble suspension was co-administered with 50 μL dextran solution via bolus injection through the tail vein 5 s prior to the start of 1-min sonication. In addition, two sham cohorts without microbubble injection were injected with either the 3 kDa or the 40 kDa dextrans to serve as the basis for comparison of successful drug delivery in the fluorescence imaging analysis.
A 1-h period was allowed after sonication to enable the dextran to circulate throughout the vasculature and to diffuse into the brain parenchyma, and then the animal was sacrificed by transcardial perfusion. The mouse brain was extracted from the skull, post-fixed in 4% paraformaldehyde overnight before sectioning for either fluorescence imaging or hematoxylin or eosin (H&E) staining in order to evaluate drug delivery efficiency and safety, respectively.
C. Evaluation of BBB opening and safety
The fluorescence intensity measurement was similarly performed following our previously reported procedure [11] . Briefly, a section representing the ventral-dorsal midline, as determined by anatomical landmarks, was first selected, and four adjacent sections were then selected on either the ventral or the dorsal side of the midline. The left (sonicated) and the right (unsonicated control) hippocampus was manually outlined using MATLAB, and the spatial average fluorescence intensity in the region of interest (ROI) was calculated using ImageJ (National Institutes of Health, Bethesda, MD, USA). The relative fluorescence enhancement was calculated by dividing the difference in fluorescence intensity between the left and the right ROIs (removing the auto-fluorescence) by the fluorescence intensity in the right ROI (the spatial average of the right hippocampus and adding twice its standard deviation). For each brain, the reported fluorescence enhancement was thus approximately equal to the sum of the relative fluorescence intensity from all nine sections.
The histological examination for safety assessment of the entire hippocampi (both left and right) was performed via hematoxylin and eosin (H&E) staining, which can be used to identify damaged neurons (dark neurons showing shrunken and triangulated cell bodies) and red blood cell extravasations (hemorrhage) [12] . Only representative brain samples (n=6) from cohorts sonicated at the highest pressure level (600 kPa) were processed in order to assess potentially the most intense damage 1 hr after sonication.
D. Quantification of Cavitation Dose
Three types of cavitation dose (SCD h , stable cavitation dose using harmonics; SCD u , stable cavitation dose using ultraharmonics; ICD, inertial cavitation dose) were quantified as described previously [11, 13] . First, each pulse of the PCD signal was calculated into the frequency spectrum in MATLAB. Second, after taking the root mean square (rms) of the voltage spectral amplitude, the harmonic signal (n*f; n = 3, 4, 5, 6; f = 1.5 MHz; maximum amplitude within a bandwidth of 20 kHz around the harmonic frequency), ultraharmonic signal (n*f+0.5*f; n = 2, 3, 4, 5; f = 1.5 MHz; maximum amplitude within a bandwidth of 20 kHz around the ultraharmonic frequency), and the broadband signal in 3-9 MHz between them (applying a comb filter to suppress the harmonic and ultraharmonic signal with rejection bandwidths of 350 kHz and 100 kHz, respectively) were separately extracted. Third, the mean harmonic, ultraharmonic, and broadband signal were taken for each pulse and summed up over all pulses received during sonication to acquire SCD h , SCD u , and ICD, respectively. Lastly, the differential cavitation doses were computed by subtracting the normalized baseline cavitation doses (30s of sonication before microbubble injection). The cavitation doses reported in this study were the differential cavitation doses.
III. RESULTS
A. Drug Delivery Efficiency
Using fluorescently-labeled dextrans as model drug molecules, the delivery efficiency due to FUS-induced BBB opening could be quantified as the relative fluorescence enhancement in the sonicated hippocampus over the control. The two sham cohorts (Group 4 for 3-kDa dextran, Group 5 for 40-kDa dextran), for which no ultrasound was applied and no microbubbles were injected, did not show any change in fluorescence intensity between the two hemispheres. To study the shell effect on delivery efficiency with various drug molecule sizes, 3-kDa (Group 1) and 40-kDa (Group 2) dextrans were used as model drugs after FUS-induced BBB opening using 100-cycle (67 μs) pulses. To study the shell effect with various sonication pulse lengths, results of 100-cycle pulses (Group 2) and 1000-cycle pulses (group 3) with 40-kDa dextrans were compared. Fig. 1 shows both the representative fluorescence images and the quantified enhancement results for Group 1 (3-kDa dextrans with 100-cycle pulses) after BBB opening. The representative fluorescence images showed homogeneous dextran diffusion within the sonicated locations with a fluorescence signal detected not only within or near large vessels, but also diffusely distributed across the entire hippocampi as the pressure increased (Fig. 1C-D, G-H, K-L) . However, the difference was found to be statistically insignificant between different shells (Fig. 1M ). Fig. 2 shows the representative fluorescence images for Group 2 (40-kDa dextrans with 100-cycle pulses). C16 microbubbles mediated the smallest dextran diffusion within the targeted hippocampi at all pressure levels. Moreover, the detectable dextran signal was predominantly contained within the blood vessels even when some diffuse fluorescence enhancement within the targeted location was obtained as the pressure was increased above 300 kPa (Fig.  2C-D) . On the other hand, significantly higher and more diffuse dextran distribution was induced using C18 and C24 microbubbles, especially at higher pressures (Fig. 2G-H, 2K -L). The quantified fluorescence analysis supported this finding (Fig. 2M) . At 450 and 600 kPa, significantly higher 40-kDa dextran delivery was detected with both C18 and C24 microbubbles compared to C16 microbubbles. In addition, C24 microbubbles induced significantly more fluorescence enhancement at 600 kPa compared to C18 microbubbles. Fig. 3 shows the representative fluorescence images for Group 3 (40-kDa dextrans with 1000-cycle pulses). Based on the fluorescence images (Fig. 3A-L) , in stark contrast with the 100-cycle BBB opening findings, the longer acoustic pulses produced significantly more homogeneous diffusion of the 40-kDa dextran, especially with the longer C18 and C24 acyl chain lengths. Punctate clusters of dextran were still visible within the vessels at all pressure levels. The quantified fluorescence enhancement results showed significantly more dextran accumulation within the targeted hippocampi after BBB opening using C24 microbubbles at 450 and 600 kPa (Fig. 3M) . On the other hand, no statistical difference in dextran delivery was detected between the C16 and C18 microbubbles across all pressure levels.
B. Acoustic Cavitation Emission
Three different types of cavitation dose (SCD h , ICD, SCD u ) were separately quantified representing different bubble activities. Stable cavitation dose with harmonics (SCD h ) was for volumetric oscillation; inertial cavitation dose (ICD) identified drastic bubble oscillation and bubble collapse; stable cavitation dose with ultraharmonics (SCD u ) typically corresponds to asymmetric bubble oscillation [13] . Fig. 4 shows the quantified acoustic cavitation dose during BBB opening. Using 100-cycle pulses, the SCD h (Fig. 4A ) for C18 and C24 was significantly higher than that of C16 at higher pressures, and the ICD and SCD u for C24 was the highest (Fig. 4B-C) . These results indicated that both C18 and C24 had stronger volumetric oscillation, and C24 had the strongest asymmetric oscillation potentially and bubble collapse over the others, corresponding to the 40-kDa dextran delivery efficiency in Fig. 2 . By increasing the pulse length to 1000 cycles (Fig. 4D-F) , the cavitation difference among shells was compensated at lower pressures except at 600 kPa where the cavitation dose for C24 remained the highest, corresponding to the 40-kDa dextran delivery efficiency in Fig. 3 .
C. Safety
Fig . 5 shows a case of BBB opening at the highest pressure (600 kPa). Examination at higher magnification did not reveal any discrete damage sites, such as clusters of dark neurons, small erythrocyte extravasations, hemorrhage or microvacuolations for brains sonicated with C16 microbubbles using either 100-or 1000-cycle pulses (Fig.  5A-B and 5G-H). Small clusters of dark neurons were identified from the representative brain that was sonicated with C18 microbubbles using 100-cycle pulses (Fig. 5C-D) , while a few petechial hemorrhages were observed within the brain parenchyma sonicated with C18 microbubbles using 1000-cycle pulses (Fig. 5I-J) . The most discernible abnormalities occurred in the C24 microbubble cohorts, for which a larger degree of microscopic perivascular hemorrhages was detected (Fig. 5E-F and 5K-L) . However, the damage to the brain parenchyma was negligible. The severity of all observed tissue damages was concluded to be Category 1 to 2 with Category 0 representing no damage. [14] .
IV. CONCLUSION
The effects of the microbubble shell physicochemical properties on drug delivery efficiency using ultrasound have been characterized using microbubbles of three phospholipids with increasing hydrophobic chain lengths (C16, C18, C24) for drug delivery to the brain through BBB opening. The entire process was monitored using passive acoustic cavitation detection (PCD) in order to shed light on the physical mechanisms behind the shell effects. The dependence on both the molecular size and acoustic energy (by varying pressure and pulse length) were studied. We showed that relatively small changes in lipid hydrophobic chain length resulted in a significant increase for large (40 kDa) but not for small (3 kDa) dextran delivery, and the acoustic energy modulated the shell effects on the delivery efficiency. The C24 microbubble was deemed to be the most efficient for large-molecule delivery. Acoustic cavitation detection identified the mechanisms associated with different shells, and the findings showed a good correlation between the delivery efficiency and tissue damage for different shelled microbubbles.
